Chen T, Wang W, Qian Y, Wang M, et al. Immune checkpoint inhibitors combined with anti-angiogenic therapy as second- or further-line treatment for small cell lung cancer: Efficacy, safety, and prognostic biomarkers. Int J Cancer 2025 Sep 1. doi: 10.1002/ijc.70102.
PMID: 40888203